Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Novel Organ-chip Platforms Likely to Transform the Drug Screening Process in the Pharmaceutical Industry
save 10 %
* Required Fields
Pay by invoice
Organ-on-a-chip technology involves the incorporation of microphysiological systems harboring dynamic living 3D organoids, tissue-culture, or cell cultures on a microfluidic platform. The physiologically relevant Organ-chip models offer a better and more precise insight to the possible in vivo effects of drugs in the human body. The flexibility of Organ-on-a-chip is such that the innovation is not just human relevant per se but can mimic a wide variety of human functions such as breathing, heart beats, peristalsis, menstruation, neuronal communication.Animal models and in vitro assays have served as the gold standard for pre-clinical research and study for a long time now. But for all the benefits, animal models and in vitro assays have seen poor results in human translation and prediction due to unsatisfactory human relevance. Organ-on-a-chip innovations are currently making themselves relevant by offering better data for human translation and prediction through their high degree of human relevant systems.US are currently the frontrunners in the Organ-on-a-chip technology followed closely by Netherlands, United Kingdom and Germany. The countries have been capitalized on the need for a better study model in drug screening application to pioneer the development of Organ-on-a-chip innovations which has seen relative success in the pharmaceutical industry as evidenced by the adoption of Organ-chip technology by major pharmaceutical companies such as Roche, AstraZeneca among many others.
Innovations in Wound Care, Ophthalmic Devices, and Artificial Intelligence-enabled Diagnostics
Innovations Transforming the Global Healthcare IT, Biomarker, Biologics, and Small Molecule Landscape
Innovations in Biomarker Analytics
Innovations in Ophthalmic, Rehabilitation, Cardiovascular and Cancer Screening Devices
Global Blockchain Technology Market in the Healthcare Industry, 2018–2022
Global Enterprise Imaging Solutions Market, Forecast to 2024
Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington's Disease and Amyotrophic Lateral Sclerosis (HD & ALS)
Analysis of the Drug Delivery Devices Market, Forecast to 2023
Innovations for the Management of Cancer, Cardiovascular, and Neurological Diseases
Innovations in Sensors, Quantum Dot Displays, Virtual Assistants, Cyber Analytics Tools, Artificial Intelligence, and Brain-computer Interfaces
solar energy market
solar energy market
well intervention market
biometric authentication market
consumer drone market
diabetes care devices market
cardiovascular devices market
natural gas market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.